Search by Drug Name or NDC
NDC 23155-0831-31 Acetazolamide 500 mg/5mL Details
Acetazolamide 500 mg/5mL
Acetazolamide is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is ACETAZOLAMIDE SODIUM.
Product Information
| NDC | 23155-0831 |
|---|---|
| Product ID | 23155-831_184ef03f-e348-4286-b501-70750b74ec2a |
| Associated GPIs | |
| GCN Sequence Number | 008163 |
| GCN Sequence Number Description | acetazolamide sodium VIAL 500 MG INJECTION |
| HIC3 | R1E |
| HIC3 Description | CARBONIC ANHYDRASE INHIBITORS |
| GCN | 34680 |
| HICL Sequence Number | 003640 |
| HICL Sequence Number Description | ACETAZOLAMIDE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Acetazolamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetazolamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/5mL |
| Substance Name | ACETAZOLAMIDE SODIUM |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202693 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0831-31 (23155083131)
| NDC Package Code | 23155-831-31 |
|---|---|
| Billing NDC | 23155083131 |
| Package | 1 VIAL, GLASS in 1 CARTON (23155-831-31) / 5 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2022-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |